- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02036346
Electrolyte Profile, Nutritional Status and Ileostomy Formation.
The Effect of Ileostomy Formation on Nutritional Status and Electrolyte Profile in Rectosigmoidectomy Patients: a Prospective Randomized Trial.
One of the main reasons for hospital readmission in ileostomy patients is fluid and electrolyte abnormalities. Prospective observational studies have suggested an occurrence rate of around 20%. Due to colonic exclusion ileostomy patients lose large amounts of sodium and fluid through their stoma effluent. In addition studies have shown that ileostomy construction is a risk factor for renal impairment, occurring secondary to dehydration.
Encouraging patients to increase total fluid intake seems to be a common mistake in clinical practice as this can dilute sodium levels even more, causing greater sodium depletion. In terms of addressing the problem a few small studies have used isotonic drinks of various compositions showing increased electrolyte absorption.
Other dietary complications sometimes include hypomagnesaemia and decreased absorption of B-12 and folic acid, however due to the integrity of the small intestine other nutrient malabsorption is unlikely to occur. As far as body composition is concerned obesity has been shown to be a risk factor for peri- and postoperative complications in colorectal surgery (e.g. peristomal dermatitis, stoma stenosis and prolapse). A prospective trial examining measures that can prevent readmission for dehydration and other nutritional considerations related to this group of patients is definitely required.
Hypothesis:
The administration of an oral rehydration solution will allow a significant decrease in dehydration and electrolyte abnormality rates in patients with a temporary ileostomy.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Thessaly
-
Larissa, Thessaly, Greece, 41110
- University Hospital Of Larissa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male of female patients of more than 18 years of age
- Patients who have undergone a rectosigmoidectomy procedure resulting or not in an ileostomy formation
Exclusion Criteria:
- Short Bowel Syndrome
- Diabetic ketoacidosis
- Chronic Renal failure
- Hepatic/Cardiac failure
- Diabetes insipidus
- Diuretic Medication
- Corticosteroid Medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Oral rehydration solution
Patients who have undergone colorectal resection surgery resulting in an ileostomy creation
|
Oral rehydration solution containing: sodium chloride, sodium citrate, glucose, magnesium citrate, food additives and water.
|
Experimental: No intervention
Patients who have undergone colorectal resection surgery resulting in an ileostomy creation
|
|
Active Comparator: Colorectal resection without an ileostomy
Patients who have undergone colorectal resection surgery without an ileostomy creation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum electrolyte levels
Time Frame: up to 20-40 days postoperatively
|
sodium (mmol/l)
|
up to 20-40 days postoperatively
|
Serum electrolyte levels
Time Frame: up to 20-40 days postoperatively
|
potassium (mmol/l)
|
up to 20-40 days postoperatively
|
Serum electrolyte levels
Time Frame: up to 20-40 days postoperatively
|
magnesium (mg/dl)
|
up to 20-40 days postoperatively
|
Serum electrolyte levels
Time Frame: up to 20-40 days postoperatively
|
chloride (mmol/l)
|
up to 20-40 days postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical findings of dehydration
Time Frame: 20 days postoperatively, 40 days postoperatively
|
thirst, dizziness, lethargy, oliguria, dense urine
|
20 days postoperatively, 40 days postoperatively
|
Biochemical markers reflecting dehydration and renal function
Time Frame: 20 days postoperativey, 40 days postoperatively
|
Urea (mg/dl)
|
20 days postoperativey, 40 days postoperatively
|
Biochemical markers reflecting dehydration and renal function
Time Frame: 20 days postoperativey, 40 days postoperatively
|
Creatinine (mg/dl)
|
20 days postoperativey, 40 days postoperatively
|
Anthropometric characteristics
Time Frame: baseline, 40 days postoperatively
|
weight (kg)
|
baseline, 40 days postoperatively
|
Anthropometric characteristics
Time Frame: baseline, 40 days postoperatively
|
height (m)
|
baseline, 40 days postoperatively
|
Anthropometric characteristics
Time Frame: baseline, 40 days postoperatively
|
BMI (kg/m2)
|
baseline, 40 days postoperatively
|
Anthropometric characteristics
Time Frame: baseline, 40 days postoperatively
|
total body fat (%)
|
baseline, 40 days postoperatively
|
Nutritional Intake
Time Frame: baseline, at 20 days and 40 days postoperatively
|
Energy intake assessed through 24hour recalls and analyzed via nutrition analysis software
|
baseline, at 20 days and 40 days postoperatively
|
Nutritional Intake
Time Frame: baseline, at 20 days and 40 days postoperatively
|
Macronutrient intake assessed through 24hour recalls and analyzed via nutrition analysis software
|
baseline, at 20 days and 40 days postoperatively
|
Nutritional Intake
Time Frame: baseline, at 20 days and 40 days postoperatively
|
Electrolyte intake via diet assessed through 24hour recalls and analyzed via nutrition analysis software
|
baseline, at 20 days and 40 days postoperatively
|
Stoma output (ml/L)
Time Frame: baseline, at 20 days and 40 days postoperatively
|
baseline, at 20 days and 40 days postoperatively
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: GEORGE TZOVARAS, MD, University Hopsital of Larissa
- Principal Investigator: Georgios D Koukoulis, M.D. MSc PhD, Department of General Surgery, University Hospital of Larisa
Publications and helpful links
General Publications
- Migdanis A, Koukoulis G, Mamaloudis I, Baloyiannis I, Migdanis I, Kanaki M, Malissiova E, Tzovaras G. Administration of an Oral Hydration Solution Prevents Electrolyte and Fluid Disturbances and Reduces Readmissions in Patients With a Diverting Ileostomy After Colorectal Surgery: A Prospective, Randomized, Controlled Trial. Dis Colon Rectum. 2018 Jul;61(7):840-846. doi: 10.1097/DCR.0000000000001082.
- Migdanis A, Koukoulis G, Mamaloudis I, Baloyiannis I, Migdanis I, Vagena X, Malissiova E, Tzovaras G. The effect of a diverting ileostomy formation on nutritional status and energy intake of patients undergoing colorectal surgery. Clin Nutr ESPEN. 2020 Dec;40:357-362. doi: 10.1016/j.clnesp.2020.08.002. Epub 2020 Aug 28.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LarissaUH
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ileostomy
-
11 Heath and Technologies LimitedThe Cleveland ClinicUnknownIleostomy; Complications | Ileostomy - StomaUnited States
-
St. Louis UniversityEpharmix, Inc.TerminatedComplication of Surgical Procedure | Ileostomy; Complications | Ileostomy - Stoma | Ileostomy Malfunction | Ileostomy UnderactiveUnited States
-
NorthShore University HealthSystemRecruitingIleostomy; Complications | Ileostomy - StomaUnited States
-
Hospital de BasurtoAlberto Loizate Totoricaguena; Pedro García AlonsoUnknownIleostomy; Complications | Ileostomy - Stoma | Stoma Ileostomy | Ileus ParalyticSpain
-
Washington University School of MedicineTerminated
-
Coloplast A/SCompleted
-
Hollister IncorporatedLondon North West Healthcare NHS Trust; St George's Healthcare NHS TrustTerminated
-
ConvaTec Inc.Completed
-
Assistance Publique - Hôpitaux de ParisCompleted
Clinical Trials on Oral Ηydration Solution
-
Foresee Pharmaceuticals Co., Ltd.CompletedHealthy VolunteersAustralia
-
Crinetics Pharmaceuticals Inc.CompletedHealthy VolunteersAustralia
-
AlzProtect SASActive, not recruitingProgressive Supranuclear PalsyFrance
-
Crinetics Pharmaceuticals Inc.CompletedHealthy VolunteersUnited States
-
Emergent BioSolutionsNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedViral InfectionUnited States
-
IRCCS Burlo GarofoloCompleted
-
Galapagos NVCompletedHealthy | PsoriasisBelgium, Moldova, Republic of, Ukraine
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Argentina, Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
-
BayerCompleted